AptarGroup, Inc.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG000BGX2S0
ATR
AptarGroup, Inc.
GICS: 15103010
·
Sector: Healthcare
·
Sub-Sector: Medical Instruments & Supplies
NAME
AptarGroup, Inc.
ISIN
US0383361039
TICKER
ATR
MIC
XNYS
REUTERS
ATR.N
BLOOMBERG
ATR US
F&G:
36
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Thu, 17.04.2025
AptarGroup
US0383361039
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.45 per share. The payment date is May 22, 2025, to stockholders of record as of May 1, 2025.
As previously announced, Aptar will hold a conference call on Friday, May 2, 2025 at ...
AptarGroup
Wed, 16.04.2025
AptarGroup
US0383361039
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announces the commencement of a clinical study to validate its proprietary SmartTrack™ platform. The platform was developed by Aptar’s drug services company, Nanopharm. If validated, SmartTrack™ aims to reduce the need f...
AptarGroup
Tue, 15.04.2025
AptarGroup
US0383361039
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has achieved the Platinum level rating in recognition of its sustainability efforts from EcoVadis for the fifth consecutive year. The Platinum rating places Aptar among the top 1% of the more than 150,000 companies rated by Ec...
AptarGroup
Thu, 27.03.2025
AptarGroup
US0383361039
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has been named one of Barron’s 100 Most Sustainable U.S. Companies for the seventh consecutive year and is ranked number 26 out of the top 100 companies for 2025.
This press release features multimedia. View the full release h...
AptarGroup
Thu, 20.03.2025
AptarGroup
US0383361039
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has been recognized for its leadership on climate change topics by the global environmental non-profit CDP, securing a place on its prestigious “A List.”
This press release features multimedia. View the full release here: http...
AptarGroup
Thu, 06.02.2025
AptarGroup
US0383361039
AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong fourth quarter results due to solid operational performance driven by top and bottom line improvements. Results were driven by sales growth in pharma solutions, increased demand for closures technologies a...
AptarGroup
Thu, 23.01.2025
AptarGroup
US0383361039
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that the Board declared a quarterly cash dividend of $0.45 per share. The payment date is February 26, 2025, to stockholders of record as of February 5, 2025.
As previously announced, Aptar will hold a confer...
AptarGroup
Tue, 14.01.2025
AptarGroup
US0383361039
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named one of America’s Most Responsible Companies 2025 by Newsweek for the sixth consecutive year. Aptar is ranked number 71 out of 600 U.S. companies.
This press release features multimedia. ...
AptarGroup
Wed, 08.01.2025
AptarGroup
US0383361039
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases.
Quarterly Conference Calls
Press Release (1...
AptarGroup
Mon, 06.01.2025
AptarGroup
US0383361039
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced their participation at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025.
Stephan Tanda, President and CEO, will present at 12:45 p.m. Eastern Standard Time. Vanessa Kanu, Execut...
AptarGroup
Information on product placements
SMART * AD
P R O D U C T S U G G E S T I O N S
